Publications by Dr Daniel Erskine - ePrints

Browsing publications by Dr Daniel Erskine.

Newcastle Authors	Title	Year
Dr David Koss Dr Pawel Palmowski Dr Andrew Porter Dr Lauren Walker Professor Johannes Attems et al.	A reciprocal relationship between markers of genomic DNA damage and alpha-synuclein pathology in dementia with Lewy bodies	2025
Dr Sean Colloby Kirsty McAleese Dr Lauren Walker Dr Daniel Erskine Dr Paul Donaghy et al.	Patterns of tau, amyloid and synuclein pathology in ageing, Alzheimer's disease and synucleinopathies	2025
Dr Daniel Erskine	The α-synuclein seed amplification assay: Interpreting a test of Parkinson's pathology	2025
Dr Calum Hamilton Professor Fiona Matthews Professor Johannes Attems Dr Paul Donaghy Dr Daniel Erskine et al.	Associations between multimorbidity and neuropathology in dementia: Consideration of functional cognitive disorders, psychiatric illness and dementia mimics	2024
Dr Tetsushi Kataura Lucy Sedlackova Niall Wilson Dr Satomi Miwa Dr Daniel Erskine et al.	Targeting the autophagy-NAD axis protects against cell death in Niemann-Pick type C1 disease models	2024
Dr Laura Alexandra Smith Dr Chun Chen Dr Nichola Lax Professor Robert Taylor Dr Daniel Erskine et al.	Astrocytic pathology in Alpers’ syndrome	2023
Dr Elizaveta Olkhova Dr Laura Alexandra Smith Carla Bradshaw Professor Grainne Gorman Dr Daniel Erskine et al.	Neurological Phenotypes in Mouse Models of Mitochondrial Disease and Relevance to Human Neuropathology	2023
Dr Chun Chen Dr David McDonald Dr Alasdair Blain Emily Mossman Kiera Atkin et al.	Parkinson’s disease neurons exhibit alterations in mitochondrial quality control proteins	2023
Dr Chun Chen Emily Mossman Dr David McDonald Dr Alasdair Blain Laura Bone et al.	Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's Disease	2022
Dr Paul Donaghy Dr Simon Cockell Dr Carmen Martin-Ruiz Dr Jonathan Coxhead Dr Joseph Kane et al.	Blood mRNA expression in Alzheimer’s disease and dementia with Lewy bodies	2022
Dr Laura Alexandra Smith Dr Daniel Erskine Dr Alasdair Blain Professor Robert Taylor Professor Bobby McFarland et al.	Delineating selective vulnerability of inhibitory interneurons Alpers' syndrome.	2022
Dr Daniel Erskine	Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage	2022
Dr Yi Ng Dr Nichola Lax Dr Alasdair Blain Dr Daniel Erskine Professor Mark Baker et al.	Forecasting stroke-like episodes and outcomes in mitochondrial disease	2022
Dr Daniel Erskine Dr Paul Donaghy Professor Ian McKeith Professor John O'Brien Professor Alan Thomas et al.	Inflammation in dementia with Lewy bodies	2022
Dr Daniel Erskine	Novel engineered nanobodies specific for N-terminal region of alpha-synuclein recognize Lewy-body pathology and inhibit in-vitro seeded aggregation and toxicity	2022
Dr David Koss Dr Daniel Erskine Dr Andrew Porter Dr Pawel Palmowski Professor Johannes Attems et al.	Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies.	2022
Chris Hatton Dr David Koss Dr Lauren Walker Professor Tiago Outeiro Professor Johannes Attems et al.	Prion-like α-synuclein pathology in the brain of infants with Krabbe disease	2022
Dr Daniel Erskine Professor Johannes Attems Professor Ian McKeith Professor Tiago Outeiro	α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity	2022
Dr Clare Tweedy Nathan Kindred Professor John-Paul Taylor Dr Daniel Erskine Dr Christopher Morris et al.	Hippocampal network hyperexcitability in young transgenic mice expressing human mutant alpha-synuclein	2021
Dr Daniel Erskine Professor Johannes Attems	Insights into Lewy body disease from rare neurometabolic disorders	2021
Dr Daniel Erskine Dr David Koss Professor Viktor Korolchuk Professor Tiago Outeiro Professor Johannes Attems et al.	Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders	2021
Dr Calum Hamilton Professor Fiona Matthews Dr Daniel Erskine Professor Johannes Attems Professor Alan Thomas et al.	Neurodegenerative brain changes are associated with area deprivation in the United Kingdom: findings from the Brains for Dementia Research study	2021
Dr Daniel Erskine Dr Christopher Morris	RT-QuIC using C-terminally truncated a-synuclein forms detects differences in seeding propensity of different brain regions from synucleinopathies	2021
Chris Hatton Dr Amy Reeve Dr Nichola Lax Dr Alasdair Blain Dr Yi Ng et al.	Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies	2020
Dr Kirsty McAleese Dr Lauren Walker Dr Daniel Erskine Mary Johnson Dr David Koss et al.	Concomitant LATE-NC in Alzheimer's disease is not associated with increased tau or amyloid-β pathological burden	2020
Dr Daniel Erskine	Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity	2020
Dr Daniel Erskine	Generation of monoclonal antibodies against phosphorylated α-Synuclein at serine 129: Research tools for synucleinopathies	2020
Dr Daniel Erskine Dr Christopher Morris Professor Johannes Attems	Investigating the Presence of Doubly‐phosphorylated α‐Synuclein at Tyrosine 125 and Serine 129 In Idiopathic Lewy Body Diseases	2020
Dr Daniel Erskine Dr Amy Reeve Dr Tuomo Polvikoski Dr Andrew Schaefer Professor Robert Taylor et al.	Lewy body pathology is more prevalent in older individuals with mitochondrial disease than controls	2020
Dr Daniel Erskine	Antibodies against alpha‐synuclein: tools and therapies	2019
Dr Daniel Erskine Professor John-Paul Taylor	Cholinergic muscarinic M₁ and M₄ receptors as therapeutic targets for cognitive, behavioural, and psychological symptoms in psychiatric and neurological disorders	2019
Professor Tiago Outeiro Dr David Koss Dr Daniel Erskine Dr Lauren Walker Dr Marzena Kurzawa-Akanbi et al.	Dementia with Lewy bodies: an update and outlook	2019
Dr Kirsty McAleese Madhurima Dey Dr Lauren Walker Dr Daniel Erskine Mary Johnson et al.	Extravascular fibrinogen in the white matter of Alzheimer’s disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer’s disease	2019
Dr Daniel Erskine Dr Christopher Morris	Heterogeneity in α-synuclein sub-types and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease	2019
Dr Lauren Walker Dr Kirsty McAleese Dr Daniel Erskine Professor Johannes Attems	Neurodegenerative Diseases and Ageing	2019
Dr Daniel Erskine	Parkinson's disease biomarkers based on alpha-synuclein	2019
Dr Daniel Erskine Professor John-Paul Taylor Professor Alan Thomas Daniel Collerton Professor Ian McKeith et al.	Pathological Changes to the Subcortical Visual System and its Relationship to Visual Hallucinations in Dementia with Lewy Bodies	2019
Dr Daniel Erskine Professor Alan Thomas Dr Ahmad Khundakar Dr Peter Hanson Professor John-Paul Taylor et al.	Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies	2018
Dr Daniel Erskine Lina Patterson Dr Athanasios Alexandris Dr Peter Hanson Professor Ian McKeith et al.	Regional levels of physiological α-synuclein are directly associated with Lewy body pathology	2018
Dr Daniel Erskine Professor Alan Thomas Professor John-Paul Taylor Michael Savage Professor Johannes Attems et al.	Neuronal Loss and Α-Synuclein Pathology in the Superior Colliculus and Its Relationship to Visual Hallucinations in Dementia with Lewy Bodies	2017
Dr Kirsty McAleese Dr Lauren Walker Mary Johnson Dr Daniel Erskine Dr Sean Colloby et al.	Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease	2017
Dr Lauren Walker Dr Kirsty McAleese Mary Johnson Dr Ahmad Khundakar Dr Daniel Erskine et al.	Quantitative neuropathology: an update on automated methodologies and implicationsfor large scale cohorts	2017
Dr Daniel Erskine Professor Alan Thomas Professor Johannes Attems Professor John-Paul Taylor Professor Ian McKeith et al.	Specific patterns of neuronal loss in the pulvinar nucleus in dementia with Lewy bodies	2017
Dr Kirsty McAleese Dr Lauren Walker Dr Daniel Erskine Professor Alan Thomas Professor Ian McKeith et al.	TDP-43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing	2017
Dr Ahmad Khundakar Dr Peter Hanson Dr Daniel Erskine Dr Nichola Lax Evangelia Karyka et al.	Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations	2016
Dr Daniel Erskine Dr Ahmad Khundakar	Stereological approaches to dementia research using human brain tissue	2016
Dr Kirsty McAleese Dr Lauren Walker Dr Daniel Erskine Professor Johannes Attems	The prevalence of TDP-43 pathology in Alzheimer's disease, Lewy body dementia and mixed Alzheimer's disease and Lewy body disease	2016
Dr Daniel Erskine Professor John-Paul Taylor Dr Michael Firbank Professor John O'Brien Professor Ian McKeith et al.	Changes to the lateral geniculate nucleus in Alzheimer's disease but not dementia with Lewy bodies	2015